Company: FTII
Filing Date: 2025-08-22
Form Type: 10-Q
Source: 0001641172-25-025250
Chunk: 95

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-08-22
Form: 10-Q
Item: Item 2
Chunk 95
---
”) with PubCo as the surviving
company of the Reorganization Merger, and (iii) immediately following the consummation of the Reorganization Merger, Longevity will merge
with and into Merger Sub (the “Acquisition Merger”) with Longevity as the surviving company of the Acquisition Merger. Following
the Acquisition Merger, Longevity will be a wholly-owned subsidiary of PubCo. At the closing of the Transactions (the “Closing”),
PubCo’s common stock, par value $0.0001 per share (the “PubCo Common Stock”), is expected to list on the Nasdaq Stock
Market LLC (“Nasdaq”) under the ticker symbol “LBIO.” The date on which the Closing actually occurs is hereinafter
referred to as the “Closing Date.”

Subject
to the terms and conditions set forth in the Amended Merger Agreement, the aggregate consideration (“Merger Consideration”)
to be paid at the Closing by PubCo to the holders of Longevity common stock, par value $0.0001 per share (“Longevity Common Stock”),
will consist of a number of shares of common stock of the Company (“PubCo Common Stock”) equal to (i) (A) $100,000,000 minus
(B) the value of each outstanding vested option to purchase Longevity Common Stock that is converted into a PubCo option, in accordance
with the Amended Merger Agreement, divided by (ii) $10.00.

On
the terms and subject to the conditions set forth in the Merger Agreement,

1.
At the effective time of the Reorganization Merger (the “Reorganization Merger Effective Time”), by virtue of the Reorganization
Merger:

(a)
each share of the Company’s Common Stock issued and outstanding immediately prior to the Reorganization Merger Effective Time shall
be converted automatically into one Purchaser Common Stock. At the Reincorporation Effective Time, all shares of the Company’s
Common Stock will cease to be outstanding and shall automatically be canceled and retired and shall cease to exist, and

(b)
(i) each unit of issued and outstanding Private Warrant of the Company shall convert automatically into a warrant to purchase one Purchaser
Class A Common Stock at a price of $11.50 per whole share of Purchaser Class A Common Stock (the “Purchaser Private Warrant”),
(ii) each issued and outstanding unit of the Company’s Public Warrant shall convert automatically into a warrant to purchase